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Poison ivy and oak urushiols or their components were 
compared with the respective esterified derivatives for 
efficacy in oral desensitization of Hartley guinea pigs 
sensitized to urushiols. The esterified derivatives pro-
duced a significantly greater degree of hyposensitization 
than did free urushiol counterparts. Suppression pro-
duced by esterified urushiols was oflonger duration than 
that produced by free urushiols. Groups of sensitized 
guinea pigs were given high (100 mg/kg) or low (10 mg/ 
kg) doses of a mixture of acetylated, saturated urushiol 
congeners over a 1-, 2-, or 3-week p e riod. High doses 
produced a greater degree of hyposensitization regard-
less of the dosage schedule used. Low doses did not 
produce significant hyposensitization unless given over 
a shorter (1 week) schedule . Large single booster doses 
(33 rug/kg/week) of the acetate derivatives produced a 
rebound in responsiveness when given, 2 weeks follow-
ing the last dose of the initial series, to animals hyposen-
sitized with 10 mg/kg. No such rebound in sensitivity 
occurred in animals given a series of high initial doses. 
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The dosage and schedule were also shown to be impor-
tant considerations for achieving maximal hyposensiti-
zation. The most important finding of this study was that 
sensitized guinea pigs can b e d esensitized or hyposensi-
tized to poison ivy and oak urushiols via the oral route. 
Antigen therapy has been a popular method used by c]jni-
cians during t his century for a ttempted reduction of the sensi-
tivity of humans to poison ivy, oak, a nd sumac (Rhus) allergens. 
The benefits and safety of the use of Rhus extracts (containing 
the active a llergenic ingredien ts, urushiols) for this pw·pose 
have been topics of dispute since they were first administered 
by physicians in 1917. Several reviews pertaining to th e c)jnical 
use of Rhus extracts and allergens have been written [1-3]. 
From these reviews two salient conclusions emerge. Firstly, 
Rhus extracts should not be used therapeutically, but rather 
prophylactically. Very small amounts of allergen should be 
given initially and extreme caut ion should be used in selecting 
and escalating the dosage, since urushiols a re highly toxic and 
can exacerbate active dermatitis [3]. Secondly, a measure of 
hyposensitization in some cases m ay be achieved but only after 
prolonged administration and after cumulative doses of 2-4 g of 
a nt igen [1). In hypersensit ive subj ects, many mon ths, and in 
so me cases over a year, may be required to achieve measw·able 
hyposensit ization. Adverse reactions to even minute doses of 
a llergen prevent the rapid escalation of doses of Rhus extracts. 
The guinea pig is the accepted animal model for study ing 
Rhus type a llergens since it can be made highly sensitive to 
urus hio.ls a nd the cutaneous reactions ar e similar to those seen 
in sensitive humans [ 4). Susceptibility to sensitization can be 
blocked in guinea pigs by injections of urushiol componen ts 
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[5], urushiol modified blood cells [6), or urushiol derivatives [7-
9] before a sensitizing dose is given. Until recently, no successful 
desensitization of sensitive guinea pigs has been reported. We 
have shown that sensitive guinea pigs can be substantially 
hyposensitized and in some cases desensitized by several in-
travenous injections of urushiol diaceta te esters [7]. Moreover, 
immune tolerance to sensitization to poison ivy allergen was 
produced in guinea pigs by a single intravenous injection of 
urushiol acetate ester before attempted topical sensit ization. 
Since the intravenous route is objectionable in attempted 
huma n desensitization, the present study was undertaken to 
determine whether orally adminjstered urushiols and their de-
rivatives would hyposensitize guinea pigs to poison ivy and oak 
urushiols. A comparison of the effectiveness of natural and ester 
derivatives of urushiols of poison ivy a nd oak was made to aid 
in the identification of a product to be used for huma n clinical 
trials. A second study was conducted to determine the optimal 
dosage and schedule for oral desensitization to poison oak 
urushiol in guinea pigs. 
MATERIALS AND METHODS 
Anim.als 
Male and female Hartley guinea pigs weighing 300-350 g were 
obtained from Camm Institu te, Wayne, New Jersey, Hilltop La bora tory 
Animals, Inc. , Scottsdale, Pennsylvania , and Glen Tremp, Mundesto, 
Cali forn ia. PUl·ina guinea pig chow and water supplemented with vi-
tamin C were available ad libitum. The guinea pigs were individually 
identified by ear tattoo and cage cards. 
Urushiol Containing Extracts of Poison Ivy and Oah Plants 
Ethanol extracts of To xicod,endron radicans (poison ivy) and T. 
diversilobum (poison oak) were obta ined from Hollister-Stie r Labora-
tories, S pokane, Washington. T he ur ushiol composition was de ter-
mined, as previously described [10], to conta in 12% and 11.5% urushiol 
i.n the ivy and oak extracts, respectively. The composition of poison ivy 
urushiol (PI U) was 13.6% saturated, 22.4% mono, 63.9% di-, and a trace 
of triolefin. T he poison oak urushiol (POU) composition was 6.8% 
mono, 10.2% di -, and 83% trio lefin. 
Synthesis of 3-n-Pentadecylcatechol (PDC) and 3-n · 
Hepladecylcatechol (HDC) 
The PDC and HDC used in some studies were prepared synthetica lly 
according to the proced ure described for the synthesis of 3-n-nonade-
cylcatechol [7] using 1-tetradecanal and 1-hexadecanal, respectively, as 
starting mate rials for the s ide chain and 2-3-dimethoxybenzylbromide 
as the starting materia l for the catechoL 
Poison Ivy and Oah Urushiol Acetate, PDC Acetate, and HDC 
Acetate 
T he procedUl·e for preparing diacetate derivatives of poison ivy and 
oak urushiol, PDC and HDC, has been published [7]. 
Sensitizing, Desensitiz ing, and Shin T est Solutions 
Sensit izing solu tions of poison ivy and oak urushiols were prepared 
in acetone to contain 1 mg urushiol in 0.15 mL Desensitizing solu t ions 
were prepared in corn oil to contain the equivalent of the active urushiol 
compound as the free catechol as follows: poison ivy or oak urushiol 
(PIU or POU, respective ly), 5 mg/ml; poison ivy or oak umshiol acetate 
(PIU or POU acetate, respective ly), 5 mg/ml; PDC aceta te, 5· mg/ml; 
HDC acetate, 5 mg/ml; PDC and HDC aceta te (1 :1) mixture, 1.1, 1.7, 
3.3, 11, 17, or 33 mg per mL Skin test solu t ions were prepared in acetone 
and contained 3, 2, 1.5, 1, 0.75, 0.5, or 0.25 11-g P I U or POU/5 11-L PDC 
test solutions contained 1.5, 0.75, and 0.375 J.!g/5/J-l acetone. 
Sensitization 
Guinea pigs were sensit ized by topical application of 1 mg of poison 
ivy or oak ur ushiol to the skin over the shoulders and dorsal neck. This 
dose of ui·ushiol produces a very brisk irritation within 24 h which heals 
within 1-2 weeks. T he sensit ization sites were not covered. Two weeks 
were a llowed for sensitivity to deve lop before init ia l skin testing. 
Skin Testing Procedures 
The skin test procedure for evalua ting poison ivy and oak sensitivity 
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has been described [7]. B riefly , the ha ir was removed from the abdom-
inal area with Oster small animal clippers using a #40 blade. S kin test 
s ites of approximately 2.5 cm2 were de lineated on the a bdominal skin 
with a nontoxic ma rker. S kin tests were of the open patch type. Five 
microli ters of each test solution was dropped from a Hamilton syringe 
onto t he skin within the de lineated s ites. 
The test s ites were evaluated at 24, 48, a nd 72 h a fte r application of 
Lest solu tions utilizing the scoring system of 0 to +4 ranked in tensity 
for erythema and edema as described by Driaze [11]. 
T he studies were performed single-blind and skin test responses were 
evaluated by one observer (SW). The responses of each guinea pig were 
scored individua lly so that the change in reactivity of each animal could 
be monitored from one test period to the next. 
Ten Lo 20 nonsensit ized negative controls were a lways included 111 
skin testing as a check for nonspecific chemical irritation. 
Oral Desensitization 
All guinea pigs were skin tested 2 weeks fo llowing sensitization to 
establish baseline sensitivity before attempted desensitization. Oral 
desensitization was a ttempted by administering the test materia l, dis-
solved in corn oil , by ora l gavage beginning the third week after 
sensitization. Control animals were dosed with corn oil. Doses were 
given on Monday, Wednesday, and Friday (MWF) for 1, 2, or 3 weeks. 
In some cases, the dose was doubled each successive week and in others 
it was held consta nt. The tota l dose administered was 10 or 100 mg/kg 
of poison ivy or oak urushiol as the free catechol or its equivalent 
weight in the form of P IU or POU acetate. In some studies, PDC 
acetate, HDC acetate, or a 1:1 mixture of the two were used for 
attempted desensitization . The doses administered were based on t he 
eq uivalent weigh t for underiva tized PDC and/or HDC and were eq uiv-
a lent to 10 or 100 mg/ kg of the free catechol. 
Effe cts of Vary ing Doses of PDC- HDC A cetate and Dosage 
Schedules on Hyposensitization to Poison Oah Urushiol 
Four hundred and fifty guinea pigs were purchased in 3 separate 
shipments (A, B, C), 150 guinea pigs per shipment. From these animals 
we were able to obtain 180 anima ls of suff icient sensitivi ty for these 
desensitization studies. ALL animals were given 1-mg sensitizing doses of 
POU after a rrival and skin tested on the back with 1.5 and 0.75 J.!g POU. 
Six ty of the most sensit ive anima ls in each shipment were randomly 
assigned to 3 groups of 20 animals each for a total of 9 groups. 
The experimental des ign is shown in Table I. One group from each 
shipment (Groups I, 4, a nd 7) served as positive contro l groups and 
were orally dosed wi th corn oil (vehicle). Another group from each 
shipment (G roups 2, 5, and 8) was given an ini t ia l series of doses of 
PDC-HDC acetate mix ture (1:1) tota ling 1.0 mg/kg per animaL A third 
group from each shipment (Groups 3, 6, a nd 9) received an ini tial series 
of doses of PDC-I-IDC acetate mixture totaling 100 mg/ kg per anima l. 
One week was a llowed between the arrival of each shipment so that 
TABLE I. Protocol to study effects of VWJ•ing dosages of PDC-HDC 
acetate, and schedules on shin lest sensitivity to p oison oah urushiol 
180 Guinea pigs' se ns itive to 1.5 p.g POU or less 
S hipment A 
60 guinea pigs, 20 per 
group, dosed ora lly 
on MWF" for 3 
consecutive weeks 
(9 equally divided 
doses): 
G roup I 
I ml/kg corn o il / day 
(total dose: 9 ml/ kg) 
Group 2 
1.1 mg/kg PDC-HDC 
acetate mixture/day 
(tota l dose: 10 mg/ 
kg) 
Group 3 
II mg/kg PDC-HDC 
acetate mi xture/day 
(tota l dose: 100 mg/ 
kg) 
S hipment B 
60 guinea pigs, 20 per 
group, dosed orally 
on MWF for 2 con-
secu tive weeks (6 
equa lly divided 
doses): 
Group 4 
1 ml/kg corn oil / day 
(total dose: 6 ml/kg) 
Group 5" 
1.7 mg/kg PDC-HDC 
ace tate m ixtu re/day 
(tota l dose: 10 mg/ 
kg) 
Group 61' 
17 mg/ kg PDC-HDC 
acetate mi xture/day 
(total dose: 100 mg/ 
kg) 
" Monday, Wednesday, and Friday. 
S hipme nt C 
60 guinea pigs, 20 per 
group, dosed ora lly 
on MWF for I 
week (3 equa lly di -
vided doses): 
Group 7 
1 ml/ kg corn o il / day 
(total dose: 3 ml/ kg) 
G roup 81' 
3.3 mg/ kg PDC-HDC 
acetate/ day 
(to tal dose: 10 mg/ 
kg) 
Group 91' 
33 mg/kg PDC-HDC 
acetate/day 
(total dose: 100 mg/ 
kg) 
"G roups 5, 6, 8, a nd 9 we re given single booster doses of 33 mg/ kg of PDC-
H DC acetate pe r week for 2 weeks, beginning 3 weeks a fter the last dose of the 
ini tial seri es. 
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the dosing of animals of Shipment A was begun l week before S hipment 
B and 2 weeks before S hipment C. This resulted in the completion of 
the initial series of doses on each group on the same day. All animals 
were then skin tested the week following the last dose of the ini tia l 
series. The dosage schedules were ar ranged so that the animals in 
Shipment A received vehicle or drug in 9 equally divided doses. A close 
was adminis tered MWF for 3 consecutive weeks. Animals in S hipment 
B were given 6 equa lly d ivided closes on MWF for 2 consecut ive weeks. 
Shipment C a nimals were dosed on MWF for a s ingle week, their tota l 
close being div ided into 3 equal doses. The week following the last dose 
of the initia l series, a ll anima ls were given kin tests of POU (2.0, 1.0, 
0.75, 0.50, a nd 0. 25 11g POU) on 5 separate abdominal skin sites. Two 
weeks following this skin test, anima ls in Groups 5, 6, 8, and 9 were 
given a s ingle oral boos ter dose of 33 mg/ kg per week for 2 consecutive 
weeks in an attempt to provide greater hyposensitiza tion . The week 
following the last booster dose, the skin tests were repeated on a ll 
animals. 
RESULTS 
Oral Desensitization. to Poison I vy and Oah Urushiol.> 
Two groups of 90 guinea pigs were purchased, one group to 
be sensit ized to POU and the other to PIU. The highly sensitive 
animals in each group were divided into groups and given oral 
doses of the respective urushiols or mushiol acetates in an 
attempt to produce desensitiziation. 
Both groups were given 1-mg sensitizing doses of POU or 
PIU and skin tested 2 weeks later with POU or PIU, respec-
tively. Two additional negative control groups of 20 guinea pigs 
each were a lso skin tested with PIU and POU as a check against 
primary irritancy of the test solutions. The skin test solu tions 
were 3.0, 1.5, 0.75, 0.5, and 0.25 11-g of the respective urushiol 
applied in a volume of 5 11-l acetone. Since there is a natural 
decline in sensitivity of guinea pigs after sensitization, only 
highly sensitive animals should be selected for desensitization 
studies. Animals failing to respond with +1 erythema to 0.75 
11-g doses of PIU or POU were eliminated fTom the study, leaving 
52 guinea pigs in the PIU-sensitive group and 25 in the POU 
group. 
Groups of 13 PIU-sensitive guinea pigs were given one of the 
following treatments orally: corn oil ; Hollister-Stier poison ivy 
extract (PIU); acetylated Hollister-Stier poison ivy extract (PIU 
acetate); or 3-n-pentadecylcatechol acetate (PDC acetate). Sim-
ilar groups (POU-, POU acetate-, HDC acetate-, and vehicle-
treated) were planned for the POD-sensitized a nimals. How-
eve r, only 25 animals were sufficiently sensitive to POU to be 
used for attempted desensitization and only 2 groups were 
established, the vehicle- and HDC acetate-treated groups. 
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Therefore, data from a preliminary study using POU a nd POU 
acetate treatments will be presented later in this section of the 
results. 
Oral dosing was begun the week fo llowing the initial skin test 
in both POU- and PIU-sensitive groups. Animals were dosed 
MWF of each week for 3 consecutive weeks. The animals were 
given corn oil (1 ml/kg) or 2.5 mg per day of PIU, PIU acetate, 
PDC acetate, or HDC acetate. The doses were increased to 5 
mg per day the second week and 10 mg per day th e t hird week. 
The total dose of urushiol per a nimal was 52.5 mg mushiol or 
the eq uivalent of 52.5 mg urushiol, in the acetate form. 
The week following the last oral dose and 4 weeks later (7 
a nd 10 weeks after sensitization, respectively) the skin tests 
with PIU or POU were repeated. The percent positive test 
responses in each group to all test doses of PIU or POU (Table 
II) were calculated for the following test periods: Pretest, initial 
skin test before attempted desen it ization; Posttest I, first skin 
test after attempted desensitization; Posttest II, second skin 
test after attempted desensitization. The percentages were cal-
culated as follows: 
# positive responses in 
. · group to all test dilutions 
% positive = -------------- x 1oo 
responses # observations/ animal 
X number of animals per group 
In order to illustrate the overall change of sensitivity within 
a group (no change, hyposensit ization, desensitization, in-
creased sensitivity) these changes were tabulated for each ani-
mal in each group. The change in sensitivity of each animal 
was obtained by comparing the highest dilution to which the 
animal was sensitive before attempted desensitization with that 
dilution after attempted desensitization. Each animal 's change 
was ta bulated according to one of the following criteria: no 
cha nge; less by 1, 2, 3, or 4 test dilutions; desensitized; increased 
sensi tivity. The percentage of each group showing each change 
is given in Table III. 
In addi t ion to the above 2 methods of comparison, the 
sensit ivity of each group was compared by the method of 
endpoint dilution as used by Baer a nd Hooton [ 4). T he geo-
metric mean dose (!lg) required to elicit a posit ive test response 
was calculated for each group. In order to calculate the geo-
metric mean it was assumed that if any animal in the group 
responded to the test substance, that all would respond to a 
dose 5 times as large as the largest dose [ 4). Therefore, animals 
TABLE II. E ffects of orally administered poison ivy or oah umshiol esters and free urushiol on shin. lest sensitivity to poison ivy and oah 
urushiol in sensitized g u.inea pigs 
Skin test periods 
Trea lmenl'' Pretest. Posttest I Posttest II 
g-roups 
% PoRitive Geometric % Positive Geometric % Positive Geometric 
responses'' mean·· responses mean responses tnean 
Corn oil 9 ml/kg 69 (13)" 0.4 205 54 (13) 0.6028 50 (13) 0.6707 
Poison ivy urushiol 74 (13) 0.3864 30 (13)" 1.5033 47 (10) 0.8261 
100 mg/ kg 
Po ison ivy urushiol 73 (13) 0.3745 20 (11) '' 2.7382 31 (ll) '' 1.3479 
acet.ate 100 mg/ kg 
PDC acetate 73 (1 3) 0.3745 47 (13) 0.9035 36 (13)' 1.9255 
Corn oil 65 (13) 0.5419 47 (12) 0.8174 37 (1 2) 1.2408 
HDC acet.ate 66 (12) 0.5274 33 (12)( 1.9130 24 (10)( 1.9873 
" Treatment refers t.o cumulated doses of corn oil , ivy or oak urushiol or their equiva lent in the acetate form. Doses were given during a 3-week 
period between Pretest. a nd PosttesL I. See text for det.a ils. 
1
' The test responses to 3.0, 1.5, 0.75, 0.5, and 0.25 11g poison ivy or oak urushiol were recorded 24, 48, and 72 h after application to test s ites. The 
number of posit ive responses of each group was divided by the number of observations (15 per animal X number of animals per group) to 
calculate % positive test r esponses. 
·· Geometric mean close (f>g) required to elicit a positive skin test response. See text for description of geometric mean. 
" Number in bracket.s = n. 
"p < 0.001, chi squa re analysis. 
r p < 0.01, chi square analysis. 
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TABLE Ill. Comparison of changes in sensitivity after a ttempted desensitization in guinea pigs treated orally with corn oil or poison ivy and 
oah uru.shiols or their acetate derivatives 
Percent of group with change in sensitivity" as compared lo pretest sensitivity 
'T'realmenl Hyposensitization 
group No change Desensitized Increased Less by l Less by 2 Less by 3 Less by 4 
lest dilu tion test di lutions lest dilu tions lest dilu tions 
Corn oi l 
Posttest I" 15.5 38.5 23 0 0 0 23 
Posttest II 38.5 23 7.5 7.5 7.5 0 15 
PIU acetate 
Posttest I 9 9 36 27 0 18 0 
Posttest II 9 0 27 9 0 27 27 
PIU 
Posttes t I 27 18 18 18 0 9 9 
Pos ttes t II 0 30 30 10 0 10 20 
PDC acetate 
Posttest 1 38 31 7.5 15 0 7.5 0 
Posttest 11 15.4 7.5 15.4 0 0 38.5 23 
Corn oi l 
Posttest 1 33 41.6 8.3 8.3 0 0 8.3 
Pos ttest II 25 8.3 25 0 8.3 8 .3 25 
HOC acetate 
Posttest 1 18 9 27.3 18 0 0 27.3 
Pos ttes t II 10 20 30 0 10 20 10 
Corn oil 
Posttest I 75 25 0 0 0 
Posttest II 75 0 0 25 0 
POU 
Posttest I 60 20 20 0 0 
Posttest li 80 0 0 20 0 
POU acetate 
Posttest I Hj.6 lG.6 33.3 33.3 0 
Posttest II 0 16.6 16.6 66.6 0 
" Percent change in sens it ivity was determined by tabu lation of t he number of animals in each group wit h the indicated change, dividing by t he 
number of anima ls tested, and mult iply ing the quotient by 100. Animals not r esponding to t he highest test dose were cons idered desens itized. 
" Pos ttests I and II a re the first a nd second skin tests a fter attempted desens itization, respective ly. 
not r esponding to the highest dose (3 11g) were assigned a 
response to 5 times that dilution (15 /lg). Draize scores were 
r ecorded and eval uated but are not shown for pur poses of 
brevity. 
A gradua l decline in sensitivity of the corn oil control groups 
over t he 10 weeks of study was observed (Tables II, III) as 
evaluated by decreasing % posit ive responses and increased 
geometric means with time. This phenomenon has been re-
ported [6], a nd is t he reason why desensit ization studies to 
poison ivy and oak in guinea pigs req uire highly sensitive 
animals at the ini t iation of the experiment. A substantia l de-
crease in the sensitivi ty of the PIU- and PIU acetate-treated 
groups was seen 1 week follo wing the last oral dose (Posttest I, 
P < 0.001 by chi square analysis). The geometric m ean of t he 
PIU acetate-treated group was almost twice as large as that of 
the PIU-treated group and 4.5 times as large as the corn oil 
control group, indicating a greater efficacy of the PIU acetate 
in reducing sensitivity. Ninety percent of the PIU-treated a ni-
mals showed a decrease in sensitivity (Table III), 2 of11 animals 
were completely desensitized 1 week following the completion 
of dosing, and no animals became sensitive to a higher dilution . 
Although the control group decreased slightly in overall sensi-
t ivity as indicated by slightly elevated geometric mean, 23% of 
the animals became sensitive to a higher dilution, 61% had 
sensiti vit ies less by 1 or 2 dilutions, and none of the control 
animals was desensitized. 
The PDC acetate-treated group was not substantially 
changed in sensitivi ty until Posttest II when both PIU acetate-
and PDC acetate-treated groups were significantly less respon-
s ive than the control (p < 0.001, Table II). Five of 13 animals 
in the PDC acetate-tested group were desensitized at Posttest 
II. The PIU -treated animals had regained their sensitivity at 
Posttest II to the level of the contro l (Table II) . 
Animals treated with HDC acetate were 2.3 times less sensi-
tive at Posttest I and 1.6 times less sensitive at P osttest II by 
comparison of geometric m eans with those of the control group 
(Table II) . Chi square analysis of the % positive vs negative test 
respo nses in the HDC acetate-treated and control group showed 
significant dift"erences (p < 0.01) at both Posttest periods. At 
Posttest II, 50% of the control group were less sensitive than 
they were at Pretest while 80% of the HDC acetate-treated 
a nimals had decreased endpoint dilutions. Two of the 10 a ni-
mals t reated with HDC acetate were desensitized. HDC acetate 
did not produce as high a rate of desensitization to POU as did 
PIU acetate a nd P DC acetate to PIU. 
A preliminary study in a small group of animals (15 guinea 
pigs) highly sensitive to PIU was conducted a nd a nimals were 
dosed orally with corn oil, POU, or POU acetate according to 
the same dosage and schedule utilized in the above experiments. 
The animals were sensitized with 1 mg PIU and skin tested 
with 1.5, 0.75, and 0.375 11g PDC before and twice after at-
tempted desensitization. The sensitivity of the POU-treated 
group did not differ from the control group at a ny test period 
(Table IV) . The POU acetate animals were substantially less 
sensitive than the controls at both Posttest periods (p < 0.001) 
and this difference was r efl ected in the frequency of positive 
test responses to PDC and increased geometric means as com-
pared to controls (Table IV) . Two of 6 POU acetate-treated 
animals were desensitized at Posttest I as compared to no 
desensitized a nimals in the POU and control groups (Table III) . 
Three of 6 POU-treated animals were hyposensitized as com-
pared to 1 out of 4 of the controls and 2 out of 5 of the POD-
treated animals at Posttest I. At the final skin test 4 out of 6 
were desensitized as compared to one each of the controls and 
POU-treated animals . The remaining 2 animals in the POU 
acetate group were hyposensitized while none of the control 
and P OU -treated a nimals was hyposensitive as compared to 
pretest endpoint dilutions. 
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E ffect of Vwying Doses of PDC-HDC Acetate and Dosage 
Schedules on Extent of Hyposensitization to Poison Oal?. 
Urushiol 
The percent of positive test responses to all test doses of 
POU at each skin test period in groups of guinea pigs give n 
cumulative oral doses of 0, 10, or 100 mg/kg of PDC-HDC 
acetate mixture (1:1) over a 3-, 2-, or 1-week period are shown 
in T able V. T he percent of posit ive test responses was calculated 
as described in the previous experiments. An average Draize 
score to t he various test doses a nd a mean average Draize score 
to all 5 dilutions was calculated for each group. 
A grad ual decline in the sens itivity of the vehicle-treated 
groups was seen over the 3 test periods (Table V). Administra-
tion of 10 mg/ kg PDC-HDC acetate over a 3-week period did 
not produce an acceleration in t his decline in sensitivity. How-
ever, comparison of the number of positive vs. negative test 
scores in the control vs. 100 mg/ kg PDC-HDC acetate-treated 
group at Posttest I showed highly significant (p < 0.001, chi 
squa re ana lysis) decreased sensitivity. There was no f·urth er 
decline in th e sens it ivity of the 100 mg/kg group at Posttest II. 
The level of sensit ivity in the 10 mg/kg PDC-HDC acetate 
group did no t differ from that observed in the control group at 
any test peri od, showing that the low dose distributed over a 3-
week peri od had no suppressive effect. T he average Draize 
scores to t he test solu t ions (Table VI) showed the same rela-
tionships as d id the frequency data. 
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The skin test reactivity of the 3 groups on the 2-week dosing 
schedule is shown in Table V. Unfortunately, a very weak 
sens it ivity in the control group makes interpretation of this 
data difficult. However, it appears that large booster doses of 
PDC-HDC acetate (33 mg/ kg/ week for 2 weeks) to the low-
dose group may have caused an increase in the sensitivity of 
these animals (p < 0.001 by chi square ana lysis of Posttest I vs. 
Posttest II responses of this group) . An increase in the mean 
Draize score for this group was noted at Posttest II (Table VII) . 
The effect of administering high a nd low doses of PDC-HDC 
acetate over a 1-week period is shown in Table V. When 10 mg/ 
kg PDC-HDC acetate was administered in 1 week, a 57% 
decrease in frequency of positive responses from t he Pretest 
freq uency was observed vs. a 19% decrease in frequency of 
responses in t he con trol group from their Pretest respon es. Chi 
squa re a nalysis of t he freq uency of positive responses in this 
group a nd the control at Posttest II showed significant de-
creased responsiveness (p < 0.001) . Administration of high 
doses over a 1-week period produ ced the same degree of hypo-
sensit ization (p < 0.001 when compared to control). However, 
2 booster doses of 33 mg/ kg/week administered to the 10 mg/ 
kg group produced a rebound in respo nsiveness which was 
significant (p < 0.001) in comparison to the control group at 
Posttest II. The Draize scores of this group (Table VIII) were 
also extremely elevated at Posttest II. The rebound effect was 
hard ly noticeable in the 100 mg/ kg group, and chi square 
a nalysis showed that the 4% increase in freq uency of t he positive 
TABLE IV . Effects of oral adm.inistration of POU acetate and free POU on shin test sensitivity to PDC in sensitized animals 
~ l ' reatmcnt" 
group 
Corn oil 9 ml/kg 
POU acetate 52.5 mg 
POU 52.5 mg 
% Positive 










Skin lest periods 
Posltest I 
% Positive Geo metric 
responses mean 
75 (4) 0.4459 
33 (6)' ' 1.556 




11 (6)' ' 
56 (5) 






" Treatmen t refers Lo cumu lated doses of corn oil, poison oak urushiol or its equivalent in t he acetate form. Doses were given during the 3-week 
period between Pretest and PosttesL I. See text for deta ils. 
" Percen t pos itive responses to 1.5, .75, and .375 p.g doses of PDC and geometric means were calculated as in Table II, footnotes band c. 
•· Geometric mean dose (p.g) required to elicit a pos itive skin Lest response. See text for descrip tion of geometric mean. 
"Numbers in brackets= n. 
•· p < 0.00 I, chi squa re ana lysis. 
TABLE V. E ffect of varying do~;a.ges and ~;ch.edule~; on ~;hin test sensitivity to poison oah urushiol in PDC-HDC acetate treated guin ea pigs 
--r rca tm cnt '' Perccnl positive test respo nses to po ison oak uru~hiol '' Schedule'' group Pretest. Posltest l Post.test II 
Corn oil 9 ml/kg MWF X 3 wk 77 (20) " 57 (20) 38 (19) 
PDC-HOC ace tate MWF X 3 wk 77 (19) 59 (19) 41 (l9) 
10 mg/ kg 
PDC-HDC aceta te MWF X :.J wk 81 (20) 40 ( l7)'' 38 (17) 
100 mg/ kg 
Co rn oil 6 ml/ kg MWF X 2 wk 50 (19) 30 (19) 29 (19) 
PDC-HDC acetate MWF X 2 wk 63 (19) 31 (19) 48 (16) 
10 mg/ kg 
PDC-HDC aceta te MWF X 2 wk 73 (20) 50 (1 8) 48 (17) 
100 mg/ kg 
Co rn oil 3 ml/kg MWF X 1 wk 63 (20) 51 (20) 46 (19) 
PDC-HDC acetate MWF X I wk 75 (20) 32 (20)'' 64 (18)' 
10 mg/ kg 
PDC-HDC acetate MWF X I wk 63 (20) 36 (20)'' 40 (19) 
100 mg/ kg 
"Treatment refers to cumulated doses of PDC-HDC acetate or corn oil. Doses were d ivided equally to obtain total dose. 
" Doses were adm inistered on MWF fo r l , 2, or 3 consecutive weeks. Test animals on 1- and 2-week schedules were given additional 33 mg/ kg 
doses on 2 consecutive weeks before posttest II . 
,. T he Lest responses to 2, 1, 0.75, 0.50, and 0.25 p.g POU were recorded 24 , 48, a nd 72 h after appl ication to test sites. The number of positive 
responses of each group were divided by the nu mber of observations (1 5 per an ima l X number of a nimal in group) to ca lculate % positive test 
responses. 
"Number in b rackets= n. 
'' p < 0.00 1, chi square ana lysis. 
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TABLE VI. Sensitivity o{ animals be{ore treatment (Pretest) and after dosing {or 3 weehs (Posttest I and II) with PDC-HDC acetate or 
corn oil 
Treatment(! Average Draize scores Lo Bkin LesLB (J.lg) of poison oak urushiol Skin Lest period group 2.0 1.5 1.0 0.75 0.50 0.25 X'' 
Corn oil contro l (l) Pretest 3.35 2.40 2.88 
Posttesl I 3.25 2.33 1.90 1.58 0.93 2.00 
Posttest II 2.23 1.65 1.32 0.88 0.39 1.29 
PDC-HDC acetate Pretest 3.07 2.35 2.71 
10 mg/kg (II) Posltest I 3.75 2.82 1.96 1.72 0.51 2.15 
Posltest II 2.49 1.74 l.l9 0.72 0.18 1.26 
PDC-HDC acetate P retest 3.05 2.38 2.72 
100 mg/ kg (III) Posttest I 2.67 1.63 1.02 1.14 0.18 1.33'' 
Posttest II 2.47 1.69 1.37 0.61 0.10 1.25 
"All groups were administered vehicle or drug 3 t imes weekly for 3 consecutive weeks. 
1
' X = mean Draize score to a ll doses used for testing during given test periods. 
,. p < 0.001 by chi square ana lysis of number of positive vs negative skin test responses in t he treated and con trol groups. 
TABLE VII. Sensitivity o{ animals be{ore (Pretest) treatment and a{ter dosing {or 2 wee/is (Posttest I and II) with PDC-HDC acetate 
'l 'reatmenl" Average Draize scores Lo skin tests (J.lg) of poison oak urushiol Skin Lest period group 2.0 1.5 1.0 0.75 0.50 0.25 x'· 
Corn oil control (I) Pretest 1.73 0.73 1.23 
Posttest I 2.04 1.35 0.89 0.47 0.14 0.98 
Posttest II 1.74 1.17 0.63 0.33 0.05 0.90 
PDC-HDC acetate Pretest 2.57 1.25 1.91 
10 mg/ kg (II) Posttest I 2.07 1.39 1.16 0.84 0.36 1.16 
Posttest II 2.25 1.56 1.13 0.83 0.50 1.25 
PDC-HDC acetate Pretest 2.85 1.38 2.ll 
100 mg/ kg (III) Posttest I 2.75 1.98 1.56 1.29 0.43 1.60 
Posttest II 2.76 1.78 1.96 0.88 0.47 1.38 
" All groups were -adm inistered vehicle or drug 3 times weekly for 2 consecutive weeks. 
''X = mean Draize score to a ll doses used fo r testing dur ing given test period. 
TABLE VIII. Sensitivity o{ animals before (Pretest) dosing and after dosing for I wee/1 (Posttest I and II) with PDC-HDC acetate or corn oil 
Treatment" Average Draize scores to skin tests (J.lg) of po ison oak urushiol Skin Lest pe riod group 2.0 1.5 1.0 0.75 0.50 0.25 X'' 
Corn oil cont rol (I) P retest 2.43 1.31 1.87 
Posttest I 3.38 2.80 1.87 1.42 0.96 2.09 
Posttest II 3.23 2.56 2.00 1.63 1.12 2.11 
PDC-HDC acetate Pretest 2.40 1.35 1.88 
10 mg/ kg (ll) Posttest I 2.93 2.33 1.82 1.32 0.86 1.85 
Posttest II 3.86 3.08 2.33 1.84 0.80 2.38'" 
PDC-HDC acetate P retest 2.00 0.87 1.44 
100 mg/ kg (Ill) Posttest I 2.50 1.55 0. 77 0.57 0.17 1. 11 c 
Posttest II 2.61 1.45 1.09 0.75 0.33 1.25 
" All groups were administered vehicle or dr ug 3 t imes weekly for 1 week. 
'' X = mean Draize score to a Ll doses used for testing during given test pe riod. 
,. p < 0.001 chi square analysis. 
responses fro m Posttest I to II was insignificant. H owever, the 
mean Draize scores for this group were also slightly elevated . 
DISCUSSION 
T he most important fi nding of this study is that guinea p igs 
can be desensit ized or substantially hyposensit ized to poison 
ivy and oak dermatitis by oral dosing. E sterifi ed urushiols were 
found to be more effective desensit izers than free urushiols. 
T he acetates of the saturated urushiol congeners, PDC and 
HDC, were also effective desensit izers. The olefini c urushiol 
congen~rs have been shown to be more potent as elicitors th a n 
aTe the saturated congeners [6] and the antigenic potency is 
increased as the num ber of do uble bonds in the alkyl side chain 
increases. It has been generally h eld that antigenic potency and 
immunosuppressive potency are linked and that the best sen-
sitizers are also the best tolerizing agents [9]. T h e findings of 
this study appeal' to support that relationship. If this is true, 
then the ideal substance to be used clinically for huma n desen-
sit ization would be the acetylated triolefini c ur ushiol congeners. 
However, the only means presently available for obtaining 
triolefini c congeners for desensit ization is by pla nt extraction 
and chroma tographic separat ion. This proc~ss is not economi-
cally feasible due to the difficulty in obtaining pla nt material 
and the expense of solvent extraction. Synthesis of the unsat-
urated congeners, particularly the di- a nd triolefins, would 
require elaborate a nd expensive procedures. Addi t ionally, ole-
finic materials are considered to be less stable than the satu-
rated congeners. Therefore, the saturat ed congeners ar e more 
Likely to be used clinically th an are th eir unsaturated counter-
par ts. 
H igh oral doses (100 mg/kg) of the diacetate esters provided 
a greater level of desensit ization than low doses (10 mg/kg) . 
Low cumulative doses provided significant desensitization when 
given over a 1-week period but not if the dose was spread 
equally over a 3-week period. Large doses provided good hy-
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posensit ization when given over a 1- or 3-week schedule. Larger 
booster doses after ini t ial desensitization appeared not to affect 
immunosuppression when given to animals desensitized on a 
high-dose schedule. However, large booster doses given to ani-
mals desensitized using a low-dose schedule produced a prom-
inent rebound in sensitivity. These findings indicate that clinical 
studies to determine the optimal dose a nd dosage schedule in 
humans will be needed. 
Relatively large oral doses (100 mg/kg; or approximately 50 
mg/animal) were required to produce hyposensitization, while 
in previous studies (7] intravenous doses of 6 mg PIU:POU 
acetate mixture (1:1) produced hyposensitization and 16 mg 
desensitized 54% of treated animals to 3.2-J.tg doses of PDC. The 
remaining animals were markedly hyposensitized. These find-
ings are in agreement with clinical findings in humans showing 
t hat smaller cumulative doses of oleoresin are required for 
maximal hyposensit ization via t he parenteral route as compar ed 
to the oral route [1]. The requirement of larger oral as compared 
to parenteral doses to produce substantial hyposensit ization is 
probably due to poor gastroin testinal a bsorption of umshiols 
fro m corn oil solutions (12]. The pattern of hyposensitization 
observed in our a nimal studies resembles that seen in humans; 
namely, hyposensitization is first noticed by a decrease in 
sensitivity to the highest dilutions. With time and continued 
administration of allergen the hyposensitization develops to the 
stronger concentrations until the a nin1als are maximally hypo-
sensit ized or desensit ized. The data in Table III illustrate this 
pattern most effectively. 
The waning of hyposensitization with time that often occurs 
in huma ns after cessation of dosing has not been observed in 
our animal studies. However, long-term follow-up studies in 
guinea pigs are hampered by the .gradual natura l decrease in 
sensitivity of the a nimals beginning 6 tc 8 weeks foll owing 
sensitization. For this same reason the benefi ts of maintenance 
doses of urushiol acetates in gu inea pigs cannot be easily 
determined. 
In addition to the superiori ty of esterified urushiol derivatives 
as desensitizing agents, comparative LD,,0 studies, local tissue 
reactions, and skin irri tation studies (data to be published 
elsewhere) showed that the esterified urushiols are substantially 
less toxic than their unclerivatizecl counterparts. The fact that 
the esterified urushiols a re more effective desensitizers and less 
tox ic points to a better therapeutic index for the urushiol esters. 
There have been clinical reports attempting to associate 
desensitization therapy with renal toxicity [13]. However, a 
chronic 6-month study in rats closed orally with free and ester-
ified urushiols (data to be published elsewhere) showed no renal 
tox icity with either form. Additionally, we have not observed 
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a ny tox ic effects from administration of the fTee or esterified 
urushiol in guinea pigs. Moreover, we have not been able to 
elicit peria nal dermatitis in guinea pigs even when 3-J.tg test 
doses of mushiol are applied directly to the anus. However, the 
guinea pig and rat may not be ideal animals in which to study 
the systemic toxic effects of urushiols since gastrointestinal 
irri tation a nd perianal dermatitis have been observed in humans 
after administration of free urushiols. 
The authors wish to tha nk Paula Whatley and Dr. Paul Skierkowski 
for assistance in the preparat ion of this manuscript.. 
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